Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart drug tested to fight COVID-19 complications

NCT ID NCT04615949

Terminated Disease control Sponsor: Cardiol Therapeutics Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a drug called CardiolRx in 90 hospitalized COVID-19 patients who also had heart disease or risk factors like diabetes or high blood pressure. The goal was to see if the drug could lower the chance of death, needing intensive care, or having heart problems. The trial was stopped early, so results are limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOVASCULAR DISEASES CARDIOVASCULAR RISK FACTOR COVID-19

Contacts and locations

Locations

  • Baylor Scott & White Health - Temple

    Temple, Texas, 76508, United States

  • Complexo Hospitalar de Niteroi- Centro de Pesquisa Clinica

    Rio de Janeiro, 24020, Brazil

  • Fundação Faculdade Regional de Medicine de Sao Jose do Rio Preto (SJRP)

    São José do Rio Preto, São Paulo, 15090-000, Brazil

  • Fundação Pio XII - Hospital de Amor Barretos

    Barretos, São Paulo, 14784-400, Brazil

  • Hospital São Lucas PUCRS

    Porto Alegre, Rio Grande do Sul, 90619-900, Brazil

  • IPECC-Instituto de Pesquisa Clínica de Campinas

    Campinas, São Paulo, 13060-080, Brazil

  • Instituto do Coração do HCFMUSP

    Cerqueira César, São Paulo, 05403-000, Brazil

  • Irmandade Santa Casa de Misericórdia

    Porto Alegre, Rio Grande do Sul, Brazil

  • JY Research Institute

    Cutler Bay, Florida, 33189, United States

  • Núcleo de Ensino e Pesquisa do Instituto Mário Penna

    Conjunto ACM, Santa Maria, 30380-472, Brazil

  • Prairie Education and Research Cooperative

    Springfield, Illinois, 62769, United States

  • SVRI- Irmandade de Santa Casa de Misercordia de Santos

    Jabaquara, São Paulo, 1409, Brazil

  • Science Valley Research Institute

    Campo Largo, Paraná, 83606, Brazil

  • Science Valley Research Institute

    Santo André, São Paulo, 1409, Brazil

  • TecSalud

    Monterrey, Nuevo León, 64718, Mexico

  • Universidade Estadual de Maringa

    Maringá, Paraná, 87020-900, Brazil

  • University of South Florida

    Tampa, Florida, 33613, United States

  • University of Texas Health Science Center

    San Antonio, Texas, 78229, United States

  • Valleywise Health Medical Center

    Phoenix, Arizona, 85008, United States

  • Westchester General Hospital

    Miami, Florida, 33155, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.